Amneal Pharmaceuticals, Inc.·4

May 5, 4:23 PM ET

TERRERI PETER R 4

4 · Amneal Pharmaceuticals, Inc. · Filed May 5, 2020

Insider Transaction Report

Form 4
Period: 2020-05-04
Transactions
  • Exercise/Conversion

    Class A Common Stock

    2020-05-04+6,45982,758 total
  • Exercise/Conversion

    Restricted Stock Units

    2020-05-046,4590 total
    Class A Common Stock (6,459 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
  • [F2]On May 6, 2019, the reporting person was granted 6,459 restricted stock units. Because the reporting person did not stand for election at the annual meeting on May 5, 2020, the restricted stock units vested on May 4, 2020 (the day prior to the first annual meeting of stockholders following the date of grant).

Documents

2 files